Compare ARK Genomic Revolution ETF (ARKG) vs Gartner Inc (IT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Gartner Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.89, while Gartner Inc trades at $139.93 (market cap $8.92B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Gartner Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | IT | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $374.40 |
52-Week Low | $23.09 | $125.68 |
Market Cap | — | $8.92B |
Enterprise Value | — | $10.51B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Gartner (IT) trades at $133.24, up 0.41% today, with a bearish technical signal but strong recent earnings beats. The company shows robust profitability with a 68.99% gross margin and 11.44% net margin, though 2025 net income declined to $729M from $1.3B in 2024. Analyst consensus is mixed with a $157.60 price target, while news highlights ongoing investigations and industry events.
Outlook is cautious due to technical bearishness and net cash outflows, but valuation appears reasonable with a P/E of 13.17. Risks include competitive pressures and the recent legal investigation. Upside potential exists if earnings momentum continues and sentiment improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Gartner Inc
Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →
